| Synergistic induction of the MUC4 mucin gene by interferon-gamma and retinoic acid in human pancreatic tumour cells involves a reprogramming of signalling pathways. Oncogene | pancreatic, |
| MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. | pancreatic, |
| HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells | pancreatic, |
| Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells. | pancreatic, |
| The mucin MUC4 is a transcriptional and post-transcriptional target of K-ras oncogene in pancreatic cancer. Implication of MAPK/AP-1, NF-kappaB and RalB signaling pathways. | pancreatic, |
| MUC4/X facilitated pancreatic cancer (PC) tumorigenesis via integrin-beta1/FAK/ERK signaling pathway. Overall, these findings revealed the novel role of MUC4/X in promoting and sustaining the oncogenic features of PC. | pancreatic, |
| Memory T cells targeting oncogenic mutations in KRAS, SMAD5, and MUC4 detected in peripheral blood of colon cancer patients have been isolated. | colorectal, |
| MUC4, a multifunctional transmembrane glycoprotein, induces oncogenic transformation of NIH3T3 mouse fibroblast cells. | None |
| MUC1 and MUC4: switching the emphasis from large to small. | None |
| the beta subunits of MUC1 and MUC4 have emerged as oncogenes [review] | None |